Filing Details

Accession Number:
0001104659-22-128617
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-20 16:02:02
Reporting Period:
2022-12-13
Accepted Time:
2022-12-20 16:02:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711933 Akoya Biosciences Inc. AKYA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1271857 P Thomas Schnettler 100 Campus Drive,6Th Floor
Marlborough MA 01762
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-13 71,050 $13.03 2,742,721 No 4 S Indirect Held by Piper Sandler Merchant Banking Fund II, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Piper Sandler Merchant Banking Fund II, L.P.
Footnotes
  1. PSC Capital Management II LLC is the general partner of Piper Sandler Merchant Banking Fund II, L.P. Piper Sandler Companies is the manager of PSC Capital Management II LLC. The reporting person is the Co-CEO of PSC Capital Management II LLC and disclaims beneficial ownership of the shares held by Piper Sandler Merchant Banking Fund II, L.P.